Target Precision Shapes Trunk Compensation After Stroke: Neuromechanical Consequences for Upper Limb Rehabilitation

Background

Paretic-arm nonuse and trunk compensation after stroke are often interpreted as impairment or learned behavior but may also reflect task-dependent optimization. We previously showed that gravitational shoulder effort and force reserve shape these behaviors. Here, we tested whether endpoint precision is an additional constraint.

Methods

Twenty-two individuals with stroke and 22 matched controls performed a seated Proximal Arm Nonuse reaching task toward small (2 cm) and large (12 cm) targets. Stroke participants were tested at normal arm weight and with the paretic arm mechanically lightened; controls were tested at normal arm weight and while holding a dumbbell corresponding to 85% of maximal voluntary shoulder force.

Results

In stroke participants, trunk compensation was 15% lower for the large target than for the small target, independently of arm weight condition (F(1,13)=8.166, p=.013, partial η²=.39). Target size did not significantly affect trunk compensation in controls or anterior deltoid activation in either group. In stroke participants, movement time was 24% longer for the small target than for the large target (F(1,13)=8.533, p=.012, partial η²=.40). In controls, the small target increased movement time only when the arm was weighted (F(1,18)=14.9, p=.001, partial η²=.45), not at normal arm weight (F(1,18)=0.158, p=.695, partial η²=.01).

Conclusions

Endpoint precision altered reaching after stroke partly independently of gravitational shoulder effort. Trunk compensation after stroke was therefore modulated by task demands rather than fixed by impairment, a pattern consistent with, although not a direct demonstration of, an optimal-control account. Rehabilitation should evaluate compensation by its functional role and the cost of suppressing it, not only by its deviation from typical kinematics, and should treat target size as an adjustable parameter of the task.

Clinical Trial: NCT04747587 . https://clinicaltrials.gov/study/NCT04747587